Revvity (RVTY) Change in Account Payables (2009 - 2026)
Revvity's (RVTY) quarterly Change in Account Payables came in at -$4.3 million in Q3 2026, up 22.53% on a YoY basis from -$3.5 million in Q3 2025, and up 68.57% quarter-over-quarter from -$13.7 million in Q2 2026.
Analysis
Revvity (RVTY) Change in Account Payables (2009 - 2026) Analysis & Trends
Revvity (RVTY) has reported Change in Account Payables for 18 consecutive years, with -$4.3 million the latest figure, recorded in Q3 2026.
- For the quarter ending Q3 2026, Change in Account Payables rose 22.53% year-over-year to -$4.3 million; the trailing twelve-month figure through Jul 2026 stood at -$14.0 million (down 6266.08% YoY), and the FY2025 full-year result was $7.3 million, up 128.22% from the prior year.
- Change in Account Payables improved to -$4.3 million in Q3 2026 per RVTY's latest filing, from -$13.7 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $26.7 million in Q2 2022 and bottomed at -$44.3 million in Q3 2023.
- Historically, Change in Account Payables has averaged -$5.6 million across 5 years, with a median of -$4.1 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Change in Account Payables tumbled 272.36% in 2024, then jumped 669.19% in 2025.
- Over 5 years, Change in Account Payables stood at $26.7 million in 2022, then plunged by 66.46% to $9.0 million in 2023, then plunged by 113.86% to -$1.2 million in 2024, then surged by 669.19% to $7.1 million in 2025, then slumped by 161.06% to -$4.3 million in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$4.3 million, -$13.7 million, and $7.1 million for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | - |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | -38.00 Mn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | -13.00 Mn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 10.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | -4.32 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | - |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | - |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 194,000.00 |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 3.29 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 5, 2026 | -4.32 Mn |
| Apr 5, 2026 | -13.74 Mn |
| Dec 28, 2025 | 7.08 Mn |
| Sep 28, 2025 | -3.01 Mn |
| Jun 29, 2025 | -5.58 Mn |
| Mar 30, 2025 | 8.85 Mn |
| Dec 29, 2024 | -1.24 Mn |
| Sep 29, 2024 | -1.81 Mn |
| Jun 30, 2024 | -4.75 Mn |
| Mar 31, 2024 | -18.23 Mn |
| Dec 31, 2023 | 8.97 Mn |
| Oct 1, 2023 | -36.17 Mn |
| Jul 2, 2023 | -44.33 Mn |
| Apr 2, 2023 | -4.90 Mn |
| Jan 1, 2023 | -3.82 Mn |
| Apr 3, 2022 | 26.74 Mn |
| Oct 3, 2021 | -13.19 Mn |
| Jul 4, 2021 | -21.75 Mn |
| Apr 4, 2021 | -5.05 Mn |
| Jan 3, 2021 | 46.84 Mn |